AstraZeneca's Total Assets for the quarter that ended in Dec. 2023 was $101,119 Mil.
Warning Sign:
If a company builds assets at 15.3% a year, faster than its revenue growth rate of 13.2% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, AstraZeneca's average Total Assets Growth Rate was 1.60% per year.
During the past 3 years, the average Total Assets Growth Rate was 19.90% per year.
During the past 5 years, the average Total Assets Growth Rate was 15.30% per year.
During the past 10 years, the average Total Assets Growth Rate was 9.80% per year.
During the past 13 years, AstraZeneca's highest 3-Year average Total Assets Growth Rate was 36.00%. The lowest was -2.50%. And the median was 5.80%.
Total Assets is connected with ROA %. AstraZeneca's annualizedROA % for the quarter that ended in Dec. 2023 was 3.89%. Total Assets is also linked to Revenue through Asset Turnover. AstraZeneca's Asset Turnover for the quarter that ended in Dec. 2023 was 0.12.
AstraZeneca Total Assets Historical Data
The historical data trend for AstraZeneca's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
AstraZeneca's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note:
The Net Income data used here is four times the quarterly (Dec. 2023) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
AstraZeneca's Asset Turnover for the quarter that ended in Dec. 2023 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
AstraZeneca Total Assets Related Terms
Thank you for viewing the detailed overview of AstraZeneca's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AZN has been successfully added to your 